This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006:26 Suppl 2:21-32.

Sirolimus, the first mTOR inhibitor

[Article in English, Spanish]

J A Sánchez-Plumed¹, M González Molina, A Alonso, M Arias

Affiliations

PMID: 17937632

Free article

Review

Sirolimus, the first mTOR inhibitor

[Article in English, Spanish]

J A Sánchez-Plumed et al. Nefrologia. 2006.

Free article

. 2006:26 Suppl 2:21-32.

Authors

J A Sánchez-Plumed¹, M González Molina, A Alonso, M Arias

Affiliation

¹ Nephrology Service, Hospital La Fe, Valencia. jasanchezp@senefro.org

PMID: 17937632

No abstract available

PubMed Disclaimer

Similar articles

Everolimus: efficacy and safety in cardiac transplantation.
Schaffer SA, Ross HJ. Schaffer SA, et al. Expert Opin Drug Saf. 2010 Sep;9(5):843-54. doi: 10.1517/14740338.2010.511611. Expert Opin Drug Saf. 2010. PMID: 20701555 Review.
Clinical evidence on the use of anti-mTOR drugs in renal transplantation.
Hernández D, Martínez D, Gutiérrez E, López V, Gutiérrez C, García P, Cobelo C, Cabello M, Burgos D, Sola E, González-Molina M. Hernández D, et al. Nefrologia. 2011;31(1):27-34. doi: 10.3265/Nefrologia.pre2010.Jul.10512. Nefrologia. 2011. PMID: 21270910 Review.
Current trends in immunosuppression.
González Posada JM. González Posada JM. Nefrologia. 2006;26 Suppl 2:3-8. Nefrologia. 2006. PMID: 17937629 Review. English, Spanish. No abstract available.
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Chapman JR, Nankivell BJ. Chapman JR, et al. Nephrol Dial Transplant. 2006 Aug;21(8):2060-3. doi: 10.1093/ndt/gfl219. Epub 2006 May 25. Nephrol Dial Transplant. 2006. PMID: 16728428 Review. No abstract available.
Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
[No authors listed] [No authors listed] Drugs R D. 1999 Jan;1(1):100-7. doi: 10.2165/00126839-199901010-00033. Drugs R D. 1999. PMID: 10566001 No abstract available.

See all similar articles

Cited by

Virtual screening and molecular dynamics simulation study of ATP-competitive inhibitors targeting mTOR protein.
Jin MY, Yu H, Deng Q, Wang Z, Wang JY, Li HL, Liang H. Jin MY, et al. PLoS One. 2025 May 5;20(5):e0319608. doi: 10.1371/journal.pone.0319608. eCollection 2025. PLoS One. 2025. PMID: 40324009 Free PMC article.
Drug Repurposing for Cancer Treatment: A Comprehensive Review.
Al Khzem AH, Gomaa MS, Alturki MS, Tawfeeq N, Sarafroz M, Alonaizi SM, Al Faran A, Alrumaihi LA, Alansari FA, Alghamdi AA. Al Khzem AH, et al. Int J Mol Sci. 2024 Nov 19;25(22):12441. doi: 10.3390/ijms252212441. Int J Mol Sci. 2024. PMID: 39596504 Free PMC article. Review.
Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application.
Liu Y, Yang F, Zou S, Qu L. Liu Y, et al. Front Pharmacol. 2019 Jan 7;9:1520. doi: 10.3389/fphar.2018.01520. eCollection 2018. Front Pharmacol. 2019. PMID: 30666207 Free PMC article. Review.

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ediciones Doyma, S.L.
Other Literature Sources
- The Lens - Patent Citations Database
Miscellaneous
- NCI CPTAC Assay Portal